Evidence map›Paper›PMID 35780277›Full record

ArticleActa diabetologica2022

Quality outcome of diabetes care during COVID-19 pandemic: a primary care cohort study.

Stefania Di Gangi, Benjamin Lüthi, Laura Diaz Hernandez, Andreas Zeller, Stefan Zechmann, Roland Fischer

Open access · hybridAbstract read
In one paragraph

Article in Acta diabetologica, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Stefania Di GangiInstitute of Primary Care, University and University Hospital Zurich, Pestalozzistrasse 24, CH-8091, Zurich, Switzerland. stefania.digangi@usz.ch.ORCID http://orcid.org/0000-0002-2847-6399
Benjamin LüthiCentre for Primary Health Care, University of Basel, Basel, Switzerland.
Laura Diaz HernandezCentre for Primary Health Care, University of Basel, Basel, Switzerland.ORCID http://orcid.org/0000-0003-3452-8797
Andreas ZellerCentre for Primary Health Care, University of Basel, Basel, Switzerland.ORCID http://orcid.org/0000-0002-6170-8745
Stefan ZechmannInstitute of Primary Care, University and University Hospital Zurich, Pestalozzistrasse 24, CH-8091, Zurich, Switzerland.ORCID http://orcid.org/0000-0001-5012-0068
Roland FischerCentre for Primary Health Care, University of Basel, Basel, Switzerland.ORCID http://orcid.org/0000-0002-4894-3564
University of Basel · CHUniversity Hospital of Zurich · CH

Funding

KHM https://khm-cmpr.ch/forschungsfonds-gewinner-2021/
6 · The paper itself

Abstract

aimManagement of diabetes care can be affected by COVID-19 pandemic control measures. This study aimed to determine the impact of the pandemic, during 17.03.2020-16.03.2021, on quality outcomes of diabetes care in general practice in Switzerland.

methodsIn this retrospective cohort study, diabetes mellitus patients (≥ 18 years) with at least one consultation at a general practitioner, during 17.03.2018-16.03.2019 (cohort 1) and 17.03.2019-16.03.2020 (cohort 2) were included and followed-up for two years. Quality indicators and outcomes of diabetes care, at patient and practitioner level, were compared before and during the pandemic. Logistic regression was performed to identify patient's risk factors for dropout from follow-up.

resultsData from 191 practices, 23,903 patients, cohort 1 and 25,092 patients, cohort 2, were analyzed. The fraction of patients lost to follow-up, attributable to the pandemic, was 28% (95% confidence interval: 25%, 30%). During the pandemic, compared to the previous year, regular measurement of weight, HbA1c, blood pressure and serum creatinine were less frequent and less patients per practitioner reached HbA1c and blood pressure target outcomes. Factors associated with continuity of care during the pandemic were: patient age 41-80 years, longer diabetes duration, diagnosis of hypertension or dyslipidemia, influenza vaccination during the last year. Risk factors for dropout were age > 80 and receiving only insulin as anti-diabetic medication.

conclusionA considerable quality reduction in diabetes mellitus care could be observed during the pandemic. Though the most vulnerable patients were not the most affected by the pandemic, key factors that might reduce dropout from follow-up were identified.

Indexed as

COVID-19Diabetes MellitusDiabetes Mellitus, Type 2AdultAgedAged, 80 and overCohort StudiesGlycated HemoglobinHumansMiddle AgedPandemicsPrimary Health CareRetrospective StudiesGlycated HemoglobinCOVID-19 pandemicDiabetes mellitusDiabetes outcomesPrimary careQuality indicators

Identifiers

PMID35780277
PMCPMC9329414
OpenAlexW4283768452

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.